Susquehanna International Group
MED icon

Susquehanna International Group’s Medifast MED Stock Holding History

Susquehanna International Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,501
Closed -$412K – 13289
2025
Q2 		$414K Buy
29,501
+16,043
+119% +$211K ﹤0.01% 9606
2025
Q1 		$181K Sell
13,458
-148,332
-92% -$2.23M ﹤0.01% 11049
2024
Q4 		$2.85M Sell
161,790
-51,724
-24% -$960K ﹤0.01% 4574
2024
Q3 		$4.09M Sell
213,514
-1,757
-0.8% -$33.9K ﹤0.01% 3962
2024
Q2 		$4.7M Buy
215,271
+206,090
+2,245% +$5.49M ﹤0.01% 3544
2024
Q1 		$352K Buy
9,181
+5,838
+175% +$283K ﹤0.01% 9333
2023
Q4 		$225K Buy
+3,343
New +$233K ﹤0.01% 10438
2023
Q3 		– Sell
-2,897
Closed -$257K – 12569
2023
Q2 		$267K Sell
2,897
-17,040
-85% -$1.52M ﹤0.01% 9673
2023
Q1 		$2.07M Buy
19,937
+7,434
+59% +$824K ﹤0.01% 5055
2022
Q4 		$1.44M Buy
12,503
+7,668
+159% +$893K ﹤0.01% 5372
2022
Q3 		$524K Buy
4,835
+1,950
+68% +$279K ﹤0.01% 8357
2022
Q2 		$521K Sell
2,885
-1,203
-29% -$215K ﹤0.01% 8158
2022
Q1 		$698K Buy
4,088
+2,070
+103% +$390K ﹤0.01% 8093
2021
Q4 		$423K Sell
2,018
-5,708
-74% -$1.18M ﹤0.01% 9611
2021
Q3 		$1.49M Buy
7,726
+6,294
+440% +$1.55M ﹤0.01% 6505
2021
Q2 		$405K Sell
1,432
-427
-23% -$116K ﹤0.01% 10099
2021
Q1 		$394K Sell
1,859
-1,269
-41% -$304K ﹤0.01% 10018
2020
Q4 		$614K Buy
3,128
+1,906
+156% +$337K ﹤0.01% 7836
2020
Q3 		$201K Buy
+1,222
New +$201K ﹤0.01% 9444
2020
Q2 		– Sell
-37,242
Closed -$3.42M – 10586
2020
Q1 		$2.33M Sell
37,242
-95
-0.3% -$8.65K ﹤0.01% 3706
2019
Q4 		$4.09M Buy
37,337
+31,861
+582% +$3.08M ﹤0.01% 3257
2019
Q3 		$567K Sell
5,476
-15,726
-74% -$1.69M ﹤0.01% 7006
2019
Q2 		$2.72M Buy
+21,202
New +$2.95M ﹤0.01% 3611
2018
Q4 		– Sell
-19,723
Closed -$3.37M – 9551
2018
Q3 		$4.37M Buy
+19,723
New +$4M ﹤0.01% 2843
2017
Q3 		– Sell
-22,085
Closed -$916K – 9304
2017
Q2 		$916K Buy
22,085
+1,585
+8% +$68.9K ﹤0.01% 5445
2017
Q1 		$910K Sell
20,500
-20,366
-50% -$877K ﹤0.01% 5328
2016
Q4 		$1.7M Hold
40,866
– – ﹤0.01% 4416
2016
Q3 		$1.54M Sell
40,866
-6,463
-14% -$232K ﹤0.01% 3991
2016
Q2 		$1.57M Buy
47,329
+26,963
+132% +$870K ﹤0.01% 3993
2016
Q1 		$615K Buy
+20,366
New +$595K ﹤0.01% 6037
2015
Q3 		– Sell
-33,225
Closed -$1.07M – 9931
2015
Q2 		$1.07M Sell
33,225
-22,975
-41% -$729K ﹤0.01% 6074
2015
Q1 		$1.68M Sell
56,200
-12,400
-18% -$394K ﹤0.01% 4651
2014
Q4 		$2.3M Buy
68,600
+26,400
+63% +$822K ﹤0.01% 4185
2014
Q3 		$1.39M Sell
42,200
-70,131
-62% -$2.15M ﹤0.01% 5288
2014
Q2 		$3.42M Buy
112,331
+73,870
+192% +$2.3M ﹤0.01% 3683
2014
Q1 		$1.12M Buy
+38,461
New +$1.03M ﹤0.01% 5318
2013
Q4 		– Sell
-27,530
Closed -$705K – 9173
2013
Q3 		$740K Buy
+27,530
New +$736K ﹤0.01% 5803

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Susquehanna International Group's MED Position: Q3 2025 in Review

Susquehanna International Group sold out of Medifast (MED) in Q3 2025, closing a stake of 29,501 shares — an estimated $412K sold.

Susquehanna International Group first reported a position in MED in Q3 2013 and held it in 37 quarters. The position peaked at $4.7M in Q2 2024. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

  • Susquehanna International Group reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 29,501 Medifast shares in Q3 2025, an estimated $412K.
  • Susquehanna International Group first reported a position in Medifast in Q3 2013 and held it in 37 quarters.
  • Susquehanna International Group's Medifast position peaked at $4.7M in Q2 2024.
  • 123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.